To specifically examine the potential associations between genetic variants in PADI4 and ESCC risk, we studied the correlation with the tagging SNP strategy in a larger cohort of 629 subjects of ESCC and 686 controls. This evidence concerns the gene PADI4 and esophageal squamous cell carcinoma.